Literature DB >> 27091376

Hypoglycemic activity of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies.

Antony Stalin1, Santiagu Stephen Irudayaraj2, Gopalsamy Rajiv Gandhi2, Kedike Balakrishna2, Savarimuthu Ignacimuthu3, Naif Abdullah Al-Dhabi4.   

Abstract

AIMS: This paper investigates the hypoglycemic activity of two derivatives of embelin (1) viz. 6-bromoembelin (2) and vilangin (3), in high-fat diet - STZ induced diabetic rats. MAIN
METHODS: The effects of 6-bromoembelin (2) and vilangin (3) on insulin resistance, β-cell dysfunction and glucose transport in high-fat diet (HFD) fed-streptozotocin (STZ) (40mg/kg) induced type 2 diabetic rats were evaluated. The binding modes of 6-bromoembelin (2) and vilangin (3) into PPARγ, PI3K, Akt, and GLUT4 were also studied using Autodock 4.2 and ADT 1.5.6 programs. KEY
FINDINGS: At the dose of 30mg/kg, the plasma glucose, plasma insulin and body weight were reduced by both embelin derivatives in diabetic rats. Additionally the altered lipid profiles and hexokinase, glucose-6-phosphatase and fructose-1,6-bisphosphatase levels were brought to normal. Compared to diabetic control group, there was a significant increase in the expression of PPARγ in epididymal adipose tissue. Inhibition of adipogenic activity and mild activation of PPARγ levels in the skeletal muscle and liver were observed. In epididymal adipose tissue, the compounds increased the insulin-mediated glucose uptake through the activation and translocation of GLUT4 in PI3K/p-Akt signaling cascade. SIGNIFICANCE: The derivatives of embelin such as 6-bromoembelin (2) and vilangin (3) may be useful in the prevention and treatment of obesity-linked type 2 diabetes mellitus.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-Bromoembelin; Biochemical analysis; Molecular-docking; PPARγ; Type 2 diabetes mellitus; Vilangin

Mesh:

Substances:

Year:  2016        PMID: 27091376     DOI: 10.1016/j.lfs.2016.04.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Changes in Titin and Collagen Modulate Effects of Aerobic and Resistance Exercise on Diabetic Cardiac Function.

Authors:  Shunchang Li; Min Liang; Derun Gao; Quansheng Su; Ismail Laher
Journal:  J Cardiovasc Transl Res       Date:  2019-02-28       Impact factor: 4.132

2.  MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats.

Authors:  Shunchang Li; Manda Wang; Jiacheng Ma; Xiaoli Pang; Jinghan Yuan; Yanrong Pan; Yu Fu; Ismail Laher
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

3.  Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats.

Authors:  Qian Zhang; Hongyue Yu; Xinhua Xiao; Ling Hu; Fengjiao Xin; Xiaobing Yu
Journal:  PeerJ       Date:  2018-03-01       Impact factor: 2.984

4.  Chemoprotective effects of butanol fraction of Buchholzia coriacea (Capparidaceae) against type 2 diabetes and oxidative stress in male Wistar rats.

Authors:  Amanda C Okolie; Oluwafemi E Kale; Odutola Osilesi
Journal:  Biosci Rep       Date:  2019-02-15       Impact factor: 3.840

Review 5.  Reviewing the Traditional/Modern Uses, Phytochemistry, Essential Oils/Extracts and Pharmacology of Embelia ribes Burm.

Authors:  Vineet Sharma; Dev Nath Singh Gautam; Andrei-Flavius Radu; Tapan Behl; Simona Gabriela Bungau; Cosmin Mihai Vesa
Journal:  Antioxidants (Basel)       Date:  2022-07-13

6.  Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats.

Authors:  Franklyn Nonso Iheagwam; Olawumi Toyin Iheagwam; Michael Kemjika Onuoha; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

7.  Terminalia catappa Extract Palliates Redox Imbalance and Inflammation in Diabetic Rats by Upregulating Nrf-2 Gene.

Authors:  Franklyn Nonso Iheagwam; Gaber El-Saber Batiha; Olubanke Olujoke Ogunlana; Shalom Nwodo Chinedu
Journal:  Int J Inflam       Date:  2021-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.